Inflammatory responses to environmental triggers are mediated by NF-κB signaling and thus activation of NF-κB is thought to play a role in the pathogenesis of asthma, COPD, and autoimmune diseases [78,79,80,81]. This evidence concerns the gene NFKB1 and autoimmune disease.